The roles of ATF2 (activating transcription factor 2) in tumorigenesis

Biochemical Society Transactions

Volumn 40, Issue 1, 2012, Pages 230-234

  Gozdecka, Malgorzata ^a   Breitwieser, Wolfgang ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Activating transcription factor 2 (ATF2); Activating transcription factor 7 (ATF7); Activator protein 1 (AP 1); C Jun N terminal kinase (JNK); Mitogen activated protein kinase (MAPK); p38

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ACTIVATING TRANSCRIPTION FACTOR 7; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN FOS; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUN; TRANSCRIPTION FACTOR MAF; TUMOR PROMOTER; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; BREAST CANCER; CARCINOGENESIS; CELL GROWTH; CELL SURVIVAL; ENZYME ACTIVITY; HUMAN; MELANOMA; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SKIN CARCINOMA; TRANSCRIPTION REGULATION;

ACTIVATING TRANSCRIPTION FACTOR 2; ACTIVATING TRANSCRIPTION FACTORS; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKOUT TECHNIQUES; GENES, TUMOR SUPPRESSOR; HUMANS; MAP KINASE SIGNALING SYSTEM; NEOPLASMS; ONCOGENES; PHOSPHORYLATION;

MAMMALIA;

EID: 84856291859     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20110630     Document Type: Review

References (50)

1. Vinson, C., Myakishev, M., Acharya, A., Mir, A.A., Moll, J.R. and Bonovich, M. (2002) Classification of human B-ZIP proteins based on dimerization properties. Mol. Cell. Biol. 22, 6321-6335
2. Goetz, J., Chatton, B., Mattei, M.G. and Kedinger, C. (1996) Structure and expression of the ATFa gene. J. Biol. Chem. 271, 29589-29598 (Pubitemid 26389580)
3. Vlahopoulos, S.A., Logotheti, S., Mikas, D., Giarika, A., Gorgoulis, V. and Zoumpourlis, V. (2008) The role of ATF-2 in oncogenesis. BioEssays 30, 314-327 (Pubitemid 351482329)
4. Derijard, B., Raingeaud, J., Barrett, T., Wu, I.H., Han, J., Ulevitch, R.J. and Davis, R.J. (1995) Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267, 682-685
5. Livingstone, C., Patel, G. and Jones, N. (1995) ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J. 14, 1785-1797
6. van Dam, H., Wilhelm, D., Herr, I., Steffen, A., Herrlich, P. and Angel, P. (1995) ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 14, 1798-1811
7. Gupta, S., Campbell, D., Derijard, B. and Davis, R.J. (1995) Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267, 389-393
8. Morrison, D.K. and Davis, R.J. (2003) Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu. Rev. Cell Dev. Biol. 19, 91-118 (Pubitemid 37487344)
9. Morton, S., Davis, R.J. and Cohen, P. (2004) Signalling pathways involved in multisite phosphorylation of the transcription factor ATF-2. FEBS Lett. 572, 177-183 (Pubitemid 39092532)
10. 69through RalGDS-Src-p38. EMBO J. 21, 3782-3793
11. Zhu, F., Zhang, Y., Bode, A.M. and Dong, Z. (2004) Involvement of ERKs and mitogen- and stress-activated protein kinase in UVC-induced phosphorylation of ATF2 in JB6 cells. Carcinogenesis 25, 1847-1852 (Pubitemid 39405903)
12. Sevilla, A., Santos, C.R., Vega, F.M. and Lazo, P.A. (2004) Human vaccinia-related kinase 1 (VRK1) activates the ATF2 transcriptional activity by novel phosphorylation on Thr-73 and Ser-62 and cooperates with JNK. J. Biol. Chem. 279, 27458-27465 (Pubitemid 38812585)
13. Yamasaki, T., Takahashi, A., Pan, J., Yamaguchi, N. and Yokoyama, K.K. (2009) Phosphorylation of activation transcription factor-2 at serine 121 by protein kinase C controls c-Jun-mediated activation of transcription. J. Biol. Chem. 284, 8567-8581
14. Bhoumik, A., Takahashi, S., Breitweiser, W., Shiloh, Y., Jones, N. and Ronai, Z. (2005) ATM-dependent phosphorylation of ATF2 is required for the DNA damage response. Mol. Cell 18, 577-587 (Pubitemid 40726234)
15. Li, S., Ezhevsky, S., Dewing, A., Cato, M.H., Scortegagna, M., Bhoumik, A., Breitwieser, W., Braddock, D., Eroshkin, A., Qi, J. et al. (2010) Radiation sensitivity and tumor susceptibility in ATM phospho-mutant ATF2 mice. Genes Cancer 1, 316-330
16. De Graeve, F., Bahr, A., Sabapathy, K.T., Hauss, C., Wagner, E.F., Kedinger, C. and Chatton, B. (1999) Role of the ATFa/JNK2 complex in Jun activation. Oncogene 18, 3491-3500 (Pubitemid 29317344)
17. Hamard, P.J., Boyer-Guittaut, M., Camuzeaux, B., Dujardin, D., Hauss, C., Oelgeschlager, T., Vigneron, M., Kedinger, C. and Chatton, B. (2007) Sumoylation delays the ATF7 transcription factor subcellular localization and inhibits its transcriptional activity. Nucleic Acids Res. 35, 1134-1144 (Pubitemid 46522967)
18. Li, X.Y. and Green, M.R. (1996) Intramolecular inhibition of activating transcription factor-2 function by its DNA-binding domain. Genes Dev. 10, 517-527
19. Sano, Y., Tokitou, F., Dai, P., Maekawa, T., Yamamoto, T. and Ishii, S. (1998) CBP alleviates the intramolecular inhibition of ATF-2 function. J. Biol. Chem. 273, 29098-29105 (Pubitemid 28507607)
20. Kawasaki, H., Song, J., Eckner, R., Ugai, H., Chiu, R., Taira, K., Shi, Y., Jones, N. and Yokoyama, K.K. (1998) p300 and ATF-2 are components of the DRF complex, which regulates retinoic acid- and E1A-mediated transcription of the c-jun gene in F9 cells. Genes Dev. 12, 233-245 (Pubitemid 28060453)
21. Cho, S.G., Bhoumik, A., Broday, L., Ivanov, V., Rosenstein, B. and Ronai, Z. (2001) TIP49b, a regulator of activating transcription factor 2 response to stress and DNA damage. Mol. Cell. Biol. 21, 8398-8413 (Pubitemid 33108600)
22. Liu, H., Deng, X., Shyu, Y.J., Li, J.J., Taparowsky, E.J. and Hu, C.D. (2006) Mutual regulation of c-Jun and ATF2 by transcriptional activation and subcellular localization. EMBO J. 25, 1058-1069 (Pubitemid 43372119)
23. Fuchs, S.Y. and Ronai, Z. (1999) Ubiquitination and degradation of ATF2 are dimerization dependent. Mol. Cell. Biol. 19, 3289-3298 (Pubitemid 29193790)
24. Fuchs, S.Y., Tappin, I. and Ronai, Z. (2000) Stability of the ATF2 transcription factor is regulated by phosphorylation and dephosphorylation. J. Biol. Chem. 275, 12560-12564 (Pubitemid 30241402)
25. Choi, J.H., Cho, H.K., Choi, Y.H. and Cheong, J. (2009) Activating transcription factor 2 increases transactivation and protein stability of hypoxia-inducible factor 1α in hepatocytes. Biochem. J. 424, 285-296
26. 2-terminal kinases target the ubiquitination of their associated transcription factors. J. Biol. Chem. 272, 32163-32168
27. Bossis, G., Malnou, C.E., Farras, R., Andermarcher, E., Hipskind, R., Rodriguez, M., Schmidt, D., Muller, S., Jariel-Encontre, I. and Piechaczyk, M. (2005) Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol. Cell. Biol. 25, 6964-6979 (Pubitemid 41105897)
28. Reimold, A.M., Grusby, M.J., Kosaras, B., Fries, J.W., Mori, R., Maniwa, S., Clauss, I.M., Collins, T., Sidman, R.L., Glimcher, M.J. and Glimcher, L.H. (1996) Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature 379, 262-265 (Pubitemid 26025212)
29. Maekawa, T., Bernier, F., Sato, M., Nomura, S., Singh, M., Inoue, Y., Tokunaga, T., Imai, H., Yokoyama, M., Reimold, A. et al. (1999) Mouse ATF-2 null mutants display features of a severe type of meconium aspiration syndrome. J. Biol. Chem. 274, 17813-17819
30. Breitwieser, W., Lyons, S., Flenniken, A.M., Ashton, G., Bruder, G., Willington, M., Lacaud, G., Kouskoff, V. and Jones, N. (2007) Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cells. Genes Dev. 21, 2069-2082 (Pubitemid 47267292)
31. Ackermann, J., Ashton, G., Lyons, S., James, D., Hornung, J.P., Jones, N. and Breitwieser, W. (2011) Loss of ATF2 function leads to cranial motoneuron degeneration during embryonic mouse development. PLoS ONE 6, e19090
32. Maekawa, T., Kim, S., Nakai, D., Makino, C., Takagi, T., Ogura, H., Yamada, K., Chatton, B. and Ishii, S. (2010) Social isolation stress induces ATF-7 phosphorylation and impairs silencing of the 5-HT 5B receptor gene. EMBO J. 29, 196-208
33. Ganiatsas, S., Kwee, L., Fujiwara, Y., Perkins, A., Ikeda, T., Labow, M.A. and Zon, L.I. (1998) SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. Proc. Natl. Acad. Sci. U.S.A. 95, 6881-6886 (Pubitemid 28278075)
34. Nishina, H., Vaz, C., Billia, P., Nghiem, M., Sasaki, T., De la Pompa, J.L., Furlonger, K., Paige, C., Hui, C., Fischer, K.D. et al. (1999) Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4. Development 126, 505-516 (Pubitemid 29082037)
35. Hilberg, F., Aguzzi, A., Howells, N. and Wagner, E.F. (1993) c-jun is essential for normal mouse development and hepatogenesis. Nature 365, 179-181 (Pubitemid 23282066)
36. Johnson, R.S., van Lingen, B., Papaioannou, V.E. and Spiegelman, B.M. (1993) A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev. 7, 1309-1317 (Pubitemid 23210880)
37. Eferl, R. and Wagner, E.F. (2003) AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3, 859-868 (Pubitemid 37383716)
38. Zoumpourlis, V., Papassava, P., Linardopoulos, S., Gillespie, D., Balmain, A. and Pintzas, A. (2000) High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model. Oncogene 19, 4011-4021
39. Papassava, P., Gorgoulis, V.G., Papaevangeliou, D., Vlahopoulos, S., van Dam, H. and Zoumpourlis, V. (2004) Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors. Cancer Res. 64, 8573-8584 (Pubitemid 39552070)
40. Recio, J.A. and Merlino, G. (2002) Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1. Oncogene 21, 1000-1008 (Pubitemid 34174512)
41. Ronai, Z., Yang, Y.M., Fuchs, S.Y., Adler, V., Sardana, M. and Herlyn, M. (1998) ATF2 confers radiation resistance to human melanoma cells. Oncogene 16, 523-531 (Pubitemid 28062080)
42. Bhoumik, A., Ivanov, V. and Ronai, Z. (2001) Activating transcription factor 2-derived peptides alter resistance of human tumor cell lines to ultraviolet irradiation and chemical treatment. Clin. Cancer Res. 7, 331-342 (Pubitemid 32183037)
43. Bhoumik, A., Huang, T.G., Ivanov, V., Gangi, L., Qiao, R.F., Woo, S.L., Chen, S.H. and Ronai, Z. (2002) An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis. J. Clin. Invest. 110, 643-650 (Pubitemid 34988788)
44. Berger, A.J., Kluger, H.M., Li, N., Kielhorn, E., Halaban, R., Ronai, Z. and Rimm, D.L. (2003) Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival. Cancer Res. 63, 8103-8107 (Pubitemid 37549453)
45. Shah, M., Bhoumik, A., Goel, V., Dewing, A., Breitwieser, W., Kluger, H., Krajewski, S., Krajewska, M., Dehart, J., Lau, E. et al. (2010) A role for ATF2 in regulating MITF and melanoma development. PLoS Genet. 6, e1001258
46. Maekawa, T., Shinagawa, T., Sano, Y., Sakuma, T., Nomura, S., Nagasaki, K., Miki, Y., Saito-Ohara, F., Inazawa, J., Kohno, T., Yokota, J. and Ishii, S. (2007) Reduced levels of ATF-2 predispose mice to mammary tumors. Mol. Cell. Biol. 27, 1730-1744
47. Bhoumik, A., Fichtman, B., Derossi, C., Breitwieser, W., Kluger, H.M., Davis, S., Subtil, A., Meltzer, P., Krajewski, S., Jones, N. and Ronai, Z. (2008) Suppressor role of activating transcription factor 2 (ATF2) in skin cancer. Proc. Natl. Acad. Sci. U.S.A. 105, 1674-1679 (Pubitemid 351346573)
48. Kaidi, A., Williams, A.C. and Paraskeva, C. (2007) Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat. Cell Biol. 9, 210-217 (Pubitemid 46420864)
49. Chen, S.Y., Takeuchi, S., Urabe, K., Hayashida, S., Kido, M., Tomoeda, H., Uchi, H., Dainichi, T., Takahara, M., Shibata, S. et al. (2008) Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous angiosarcoma and pyogenic granuloma. J. Cutaneous Pathol. 35, 722-730
50. Jones, S., Zhang, X., Parsons, D.W., Lin, J.C., Leary, R.J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A. et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801-1806